Maria Lucia Reale

18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival

Giulia Polverari, Francesco Ceci, Valentina Bertaglia et al. · Cancers · 2020 · 97 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics

Laura Mezquita, Isabel R. Preeshagul, Édouard Auclin et al. · European Journal of Cancer · 2021 · 60 citations · Full text

Medicine, Immunology, Oncology +12

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study

Laura Marandino, Federica Trastu, Eleonora Ghisoni et al. · BMJ Oncology · 2023 · 25 citations · Full text

Pharmacy, Oncology, Comparative Effectiveness Research +16

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features

Antonio Passaro, Silvia Novello, Diana Giannarelli et al. · Cancers · 2021 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program

Francesco Passiglia, Maria Lucia Reale, Giuseppe Lo Russo et al. · Lung Cancer · 2023 · 24 citations · Full text

Medicine, Oncology, Pharmacotherapy +17